Granite Investment Partners’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,528
Closed -$123K 351
2019
Q3
$123K Hold
13,528
0.01% 335
2019
Q2
$137K Sell
13,528
-11,854
-47% -$135K 0.01% 341
2019
Q1
$356K Buy
25,382
+103
+0.4% +$1.77K 0.02% 318
2018
Q4
$401K Hold
25,279
0.03% 272
2018
Q3
$475K Hold
25,279
0.03% 244
2018
Q2
$487K Hold
25,279
0.03% 232
2018
Q1
$540K Sell
25,279
-42,222
-63% -$877K 0.04% 213
2017
Q4
$1.39M Hold
67,501
0.09% 173
2017
Q3
$1.24M Sell
67,501
-36,764
-35% -$809K 0.08% 186
2017
Q2
$2.6M Sell
104,265
-5,399
-5% -$113K 0.18% 135
2017
Q1
$2.2M Sell
109,664
-4,260
-4% -$93.5K 0.15% 144
2016
Q4
$2.81M Sell
113,924
-10,238
-8% -$229K 0.21% 129
2016
Q3
$2.46M Buy
124,162
+5,135
+4% +$95.2K 0.18% 143
2016
Q2
$1.64M Sell
119,027
-12,741
-10% -$177K 0.13% 176
2016
Q1
$1.81M Buy
131,768
+24,506
+23% +$281K 0.16% 154
2015
Q4
$1.09M Sell
107,262
-11,127
-9% -$121K 0.1% 202
2015
Q3
$1.19M Buy
118,389
+47,954
+68% +$559K 0.11% 194
2015
Q2
$1.04M Sell
70,435
-17,811
-20% -$277K 0.1% 206
2015
Q1
$1.46M Buy
88,246
+23,604
+37% +$368K 0.13% 186
2014
Q4
$979K Buy
64,642
+37,779
+141% +$549K 0.11% 219
2014
Q3
$380K Buy
26,863
+735
+3% +$10.4K 0.05% 236
2014
Q2
$370K Buy
26,128
+353
+1% +$5.36K 0.05% 240
2014
Q1
$442K Sell
25,775
-4,375
-15% -$72.5K 0.07% 178
2013
Q4
$443K Hold
30,150
0.07% 197
2013
Q3
$399K Sell
30,150
-160
-0.5% -$1.99K 0.06% 193
2013
Q2
$326K Buy
+30,310
New +$341K 0.06% 214

Other funds holding PMD

Granite Investment Partners's PMD Position: Q4 2019 in Review

Granite Investment Partners sold out of Psychemedics Corporation (PMD) in Q4 2019, closing a stake of 13,528 shares — an estimated $123K sold.

Granite Investment Partners first reported a position in PMD in Q2 2013 and held it in 26 quarters. The position peaked at $2.81M in Q4 2016. 42 funds tracked by Wall St. Rank hold PMD as of Q4 2019.

  • Granite Investment Partners reported no remaining Psychemedics Corporation position as of Q4 2019 after selling out during the quarter.
  • Granite Investment Partners sold 13,528 Psychemedics Corporation shares in Q4 2019, an estimated $123K.
  • Granite Investment Partners first reported a position in Psychemedics Corporation in Q2 2013 and held it in 26 quarters.
  • Granite Investment Partners's Psychemedics Corporation position peaked at $2.81M in Q4 2016.
  • 42 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2019.

Based on Granite Investment Partners's 13F filing for Q4 2019, filed 10 Feb 2020.